SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (281)12/14/1998 1:58:00 PM
From: Anthony Wong  Respond to of 656
 
Immunex Corp. Reiterated 'Buy' at Adams, Harkness

Bloomberg News
December 14, 1998, 9:05 a.m. ET

Princeton, New Jersey, Dec. 14 (Bloomberg Data) -- Immunex Corp. (IMNX US)
was reiterated ''buy'' by analyst Carol Werther at Adams, Harkness & Hill.
The 12-month target price is $122.00 per share.

-- Andrew Bekoff in Princeton, New Jersey, (609)279-3652

More News: IMNX



To: Anthony Wong who wrote (281)12/14/1998 2:02:00 PM
From: Anthony Wong  Read Replies (2) | Respond to of 656
 
Immunex Corp. Reiterated 'Buy' at Salomon Smith Barney

Bloomberg News
December 14, 1998, 11:37 a.m. ET

Princeton, New Jersey, Dec. 14 (Bloomberg Data) -- Immunex Corp. (IMNX US)
was reiterated ''buy'' by analyst Meirav Chovav at Salomon Smith Barney.
The 12-month target price is $120.00 per share.

-- Andrew Bekoff in Princeton, New Jersey, (609)279-3652